ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 257

$545K Total Retail Price of All Prescriptions

Rank: 19 out of 257

322 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Hampshire
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
WARFARIN SODIUM 867 841 44 1 13
FUROSEMIDE 426 415 77 2 7
AMLODIPINE BESYLATE 401 396* 60 3 4
LEVOTHYROXINE SODIUM 394 389* 58 4 2
METOPROLOL TARTRATE 308 303* 60 5 8
LISINOPRIL 284 273 51 6 1
CYMBALTA 232 227* 19 7 42
GABAPENTIN 192 181 37 8 15
NAMENDA 169 164* 17 9 39
RISPERIDONE 162 157* 22 A 10 62
SIMVASTATIN 161 145 35 11 3
POTASSIUM CHLORIDE 160 155* 35 12 37
CITALOPRAM HBR 150 118 30 13 19
OMEPRAZOLE 143 129 34 14 6
ATORVASTATIN CALCIUM 140 135* 32 15 5
ESCITALOPRAM OXALATE 130 125* 19 16 41
TRAZODONE HCL 129 124* 23 17 25
SERTRALINE HCL 128 123* 20 18 20
LEVETIRACETAM 124 119* 15 19 94
POLYETHYLENE GLYCOL 3350 120 115* 35 20 54
CLOPIDOGREL 119 114* 19 21 30
IPRATROPIUM-ALBUTEROL 119 96 30 21 75
ABILIFY 113 <11 <11 A 23 88
TRAMADOL HCL 109 104* 27 24 24
ATENOLOL 106 101* 19 25 12
METOPROLOL SUCCINATE 105 100* 31 26 11
PREDNISONE 105 100* 28 26 33
PANTOPRAZOLE SODIUM 102 97* 34 28 17
SPIRIVA 99 94* 23 29 43
NYSTATIN 99 94* 32 29 141
TAMSULOSIN HCL 97 92* 22 31 27
ADVAIR DISKUS 97 92* 21 31 28
QUETIAPINE FUMARATE 91 86* 17 A 33 48
VENLAFAXINE HCL ER 88 83* 11 34 81
METFORMIN HCL 87 82* 19 35 10
DONEPEZIL HCL 86 81* 15 36 34
LIDODERM 82 77* 26 37 90
MIRTAZAPINE 82 77* 16 37 47
OLANZAPINE 81 <11 <11 A 39 85
LEVEMIR FLEXPEN 80 75* 15 40 99
ALLOPURINOL 79 <11 <11 41 32
CRESTOR 73 73 13 42 21
ROPINIROLE HCL 72 67* 11 43 78
NEXIUM 71 <11 <11 44 31
CARVEDILOL 71 71 16 44 46
DILTIAZEM 24HR CD 70 65* 13 46 136
LACTULOSE 68 63* 18 47 163
LOVASTATIN 62 <11 <11 48 38
JANUVIA 61 <11 <11 49 71
ISOSORBIDE MONONITRATE ER 61 56* 14 49 87
GLIPIZIDE 60 <11 <11 51 60
DIVALPROEX SODIUM 56 <11 <11 52 91
CIPROFLOXACIN HCL 54 49* 30 53 130
CLONIDINE HCL 53 <11 <11 54 127
FAMOTIDINE* 52 47* 16 55 68
LORAZEPAM 51 46* 18 B 56 18
COLCRYS 51 <11 <11 56 218
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.